EW Q1 2018 Earnings — Edwards Lifesciences Corporation Revenue & Financial Results | Market Cap Arena

EWEdwards Lifesciences Corporation

$49B

Q1 2018 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$895M+1.3% YoY

Gross Profit

$663M74.1% margin

Operating Income

$265M29.6% margin

Net Income

$207M23.1% margin

EPS (Diluted)

$0.32

QoQ Revenue Growth

+0.7%

Cash Flow

Operating Cash Flow

$151M

Free Cash Flow

$105M

Stock-Based Comp.

$18M

Balance Sheet

Total Assets

$5.8B

Total Liabilities

$2.6B

Stockholders' Equity

$3.2B

Cash & Equivalents

$1.2B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$895M	$884M	+1.3%
Gross Profit	$663M	$665M	-0.4%
Operating Income	$265M	$308M	-14.0%
Net Income	$207M	$230M	-10.3%

Revenue Segments

Transcatheter Heart Valves

$552M62%

Surgical Heart Valve Therapy

$180M20%

Critical Care

$164M18%

Geographic Segments

UNITED STATES

$480M54%

Europe

$230M26%

JAPAN

$93M10%

Rest of World

$93M10%